Baraclude and Viread to drive market growth in Korea

Published: 2011-05-20 06:57:00
Updated: 2011-05-20 06:57:00
The domestic hepatitis B market is expected to witness significant changes as Yuhan’s Viread (tenofovir) is to be launched in the latter half of this year.

Currently, BMS’s Varaclude (entecavir) has led the domestic market with 90 billion won in sales last year, but Baraclude does not offer a ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.